SK4397A3 - Acyl azolones, manufacturing process thereof, pharmauceutical compositions on their base and process for producing them - Google Patents
Acyl azolones, manufacturing process thereof, pharmauceutical compositions on their base and process for producing them Download PDFInfo
- Publication number
- SK4397A3 SK4397A3 SK43-97A SK4397A SK4397A3 SK 4397 A3 SK4397 A3 SK 4397A3 SK 4397 A SK4397 A SK 4397A SK 4397 A3 SK4397 A3 SK 4397A3
- Authority
- SK
- Slovakia
- Prior art keywords
- formula
- alkyl
- phenyl
- pharmaceutically acceptable
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/70—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/12—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Polymerization Catalysts (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP94202019 | 1994-07-12 | ||
PCT/EP1995/002618 WO1996001822A1 (en) | 1994-07-12 | 1995-07-05 | Anti-helicobacter acyl derivatives of azolones |
Publications (1)
Publication Number | Publication Date |
---|---|
SK4397A3 true SK4397A3 (en) | 1997-11-05 |
Family
ID=8217032
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK43-97A SK4397A3 (en) | 1994-07-12 | 1995-07-05 | Acyl azolones, manufacturing process thereof, pharmauceutical compositions on their base and process for producing them |
Country Status (21)
Country | Link |
---|---|
US (1) | US5637592A (hu) |
EP (1) | EP0770074A1 (hu) |
JP (1) | JPH10502385A (hu) |
CN (1) | CN1071331C (hu) |
AU (1) | AU685310B2 (hu) |
BR (1) | BR9508377A (hu) |
CA (1) | CA2193490A1 (hu) |
CZ (1) | CZ2897A3 (hu) |
FI (1) | FI970112A0 (hu) |
HU (1) | HUT76638A (hu) |
IL (1) | IL114536A (hu) |
MX (1) | MX9700342A (hu) |
MY (1) | MY131727A (hu) |
NO (1) | NO310290B1 (hu) |
NZ (1) | NZ290118A (hu) |
PH (1) | PH31455A (hu) |
PL (1) | PL318140A1 (hu) |
RU (1) | RU2152392C1 (hu) |
SK (1) | SK4397A3 (hu) |
WO (1) | WO1996001822A1 (hu) |
ZA (1) | ZA955759B (hu) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6312712B1 (en) | 1999-08-26 | 2001-11-06 | Robert R. Whittle | Method of improving bioavailability |
US6780880B1 (en) | 1999-08-26 | 2004-08-24 | Robert R. Whittle | FT-Raman spectroscopic measurement |
US6268385B1 (en) | 1999-08-26 | 2001-07-31 | Robert R. Whittle | Dry blend pharmaceutical formulations |
US6326384B1 (en) | 1999-08-26 | 2001-12-04 | Robert R. Whittle | Dry blend pharmaceutical unit dosage form |
US6312723B1 (en) | 1999-08-26 | 2001-11-06 | Robert R. Whittle | Pharmaceutical unit dosage form |
US6262085B1 (en) | 1999-08-26 | 2001-07-17 | Robert R. Whittle | Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
US6369087B1 (en) | 1999-08-26 | 2002-04-09 | Robert R. Whittle | Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
US6316020B1 (en) | 1999-08-26 | 2001-11-13 | Robert R. Whittle | Pharmaceutical formulations |
US6262086B1 (en) | 1999-08-26 | 2001-07-17 | Robert R. Whittle | Pharmaceutical unit dosage form |
US20050119251A1 (en) * | 2001-12-21 | 2005-06-02 | Jian-Min Fu | Nicotinamide derivatives and their use as therapeutic agents |
AU2004221812B2 (en) * | 2003-03-19 | 2010-02-18 | Exelixis Inc. | Tie-2 modulators and methods of use |
PT1791830E (pt) * | 2004-09-17 | 2011-04-04 | Vertex Pharma | Compostos de diaminotriazole úteis como inibidores de proteína-quinase |
MX2007003332A (es) * | 2004-09-20 | 2007-06-05 | Xenon Pharmaceuticals Inc | Derivados heterociclicos y su uso como inhibidores de estearoil-coa-desaturasa. |
BRPI0515488A (pt) * | 2004-09-20 | 2008-07-29 | Xenon Pharmaceuticals Inc | derivados de heterocìclicos e seu uso como agentes terapêuticos |
WO2006034440A2 (en) * | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors |
TW200626139A (en) * | 2004-09-20 | 2006-08-01 | Xenon Pharmaceuticals Inc | Heterocyclic derivatives and their use as therapeutic agents |
TW200626572A (en) * | 2004-09-20 | 2006-08-01 | Xenon Pharmaceuticals Inc | Heterocyclic derivatives and their use as therapeutic agents |
WO2006034446A2 (en) * | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Pyridine derivatives for inhibiting human stearoyl-coa-desaturase |
EP1814551A2 (en) * | 2004-09-20 | 2007-08-08 | Xenon Pharmaceuticals Inc. | Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase |
AR051294A1 (es) * | 2004-09-20 | 2007-01-03 | Xenon Pharmaceuticals Inc | Derivados heterociclicos y su uso como inhibidores de la estearoil-coa desaturasa |
BRPI0515483A (pt) | 2004-09-20 | 2008-07-22 | Xenon Pharmaceuticals Inc | derivados heterocìclicos para o tratamento de doenças mediadas por enzimas estearoil-coa desaturase |
EP2540296A1 (en) | 2005-06-03 | 2013-01-02 | Xenon Pharmaceuticals Inc. | Arminothiazole derivatives as human stearoyl-coa desaturase inhibitors |
JO2972B1 (en) | 2007-06-08 | 2016-03-15 | جانسين فارماسوتيكا ان. في | Piperidine / piperazine derivatives |
WO2008148851A1 (en) | 2007-06-08 | 2008-12-11 | Janssen Pharmaceutica N.V. | Piperidine/piperazine derivatives |
CA2687912C (en) * | 2007-06-08 | 2015-11-03 | Janssen Pharmaceutica N.V. | Piperidine/piperazine derivatives |
AU2008258487B2 (en) | 2007-06-08 | 2012-11-15 | Janssen Pharmaceutica N.V. | Piperidine/piperazine derivatives |
EP2801565B1 (en) | 2013-05-06 | 2015-07-22 | King Saud University | Compounds for use as anti-ulcer agent and/or anti-Helicobacter pylori agent and pharmaceutical compositions thereof |
SI3221308T1 (sl) * | 2014-11-21 | 2018-12-31 | F2G Limited | Antimikotiki |
GB201609222D0 (en) | 2016-05-25 | 2016-07-06 | F2G Ltd | Pharmaceutical formulation |
US11819503B2 (en) | 2019-04-23 | 2023-11-21 | F2G Ltd | Method of treating coccidioides infection |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4791111A (en) * | 1985-12-23 | 1988-12-13 | Janssen Pharmaceutica, N.V. | [[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]methyl]-1H-imidazoles and 1H-1,2,4-triazoles having anti-microbial properties |
CA1331757C (en) * | 1988-02-29 | 1994-08-30 | Janssen Pharmaceutica Naamloze Vennootschap | 5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols |
TW218017B (hu) * | 1992-04-28 | 1993-12-21 | Takeda Pharm Industry Co Ltd | |
TW279864B (hu) * | 1993-02-19 | 1996-07-01 | Janssen Pharmaceutica Nv | |
US5571811A (en) * | 1994-07-12 | 1996-11-05 | Janssen Pharmaceutica N.V. | Sulfonamide derivatives of azolones |
-
1995
- 1995-05-23 US US08/448,082 patent/US5637592A/en not_active Expired - Fee Related
- 1995-06-02 PH PH50650A patent/PH31455A/en unknown
- 1995-07-05 HU HU9700076A patent/HUT76638A/hu unknown
- 1995-07-05 JP JP8504111A patent/JPH10502385A/ja active Pending
- 1995-07-05 RU RU97102153/04A patent/RU2152392C1/ru active
- 1995-07-05 BR BR9508377A patent/BR9508377A/pt not_active Application Discontinuation
- 1995-07-05 CA CA002193490A patent/CA2193490A1/en not_active Abandoned
- 1995-07-05 WO PCT/EP1995/002618 patent/WO1996001822A1/en not_active Application Discontinuation
- 1995-07-05 NZ NZ290118A patent/NZ290118A/en unknown
- 1995-07-05 AU AU30757/95A patent/AU685310B2/en not_active Ceased
- 1995-07-05 CZ CZ9728A patent/CZ2897A3/cs unknown
- 1995-07-05 SK SK43-97A patent/SK4397A3/sk unknown
- 1995-07-05 CN CN95194023A patent/CN1071331C/zh not_active Expired - Fee Related
- 1995-07-05 MX MX9700342A patent/MX9700342A/es unknown
- 1995-07-05 PL PL95318140A patent/PL318140A1/xx unknown
- 1995-07-05 EP EP95926392A patent/EP0770074A1/en not_active Withdrawn
- 1995-07-11 ZA ZA955759A patent/ZA955759B/xx unknown
- 1995-07-11 IL IL11453695A patent/IL114536A/xx active IP Right Grant
- 1995-07-12 MY MYPI95001970A patent/MY131727A/en unknown
-
1997
- 1997-01-09 NO NO19970088A patent/NO310290B1/no unknown
- 1997-01-10 FI FI970112A patent/FI970112A0/fi unknown
Also Published As
Publication number | Publication date |
---|---|
US5637592A (en) | 1997-06-10 |
CN1152311A (zh) | 1997-06-18 |
HU9700076D0 (en) | 1997-02-28 |
NO970088L (no) | 1997-03-10 |
RU2152392C1 (ru) | 2000-07-10 |
FI970112A (fi) | 1997-01-10 |
PL318140A1 (en) | 1997-05-12 |
CZ2897A3 (en) | 1997-10-15 |
FI970112A0 (fi) | 1997-01-10 |
ZA955759B (en) | 1997-01-13 |
NO970088D0 (no) | 1997-01-09 |
IL114536A (en) | 1999-04-11 |
IL114536A0 (en) | 1995-11-27 |
HUT76638A (en) | 1997-10-28 |
JPH10502385A (ja) | 1998-03-03 |
CN1071331C (zh) | 2001-09-19 |
AU3075795A (en) | 1996-02-09 |
NZ290118A (en) | 1997-11-24 |
NO310290B1 (no) | 2001-06-18 |
BR9508377A (pt) | 1997-10-28 |
PH31455A (en) | 1998-11-03 |
MX9700342A (es) | 1997-05-31 |
EP0770074A1 (en) | 1997-05-02 |
MY131727A (en) | 2007-08-30 |
WO1996001822A1 (en) | 1996-01-25 |
CA2193490A1 (en) | 1996-01-25 |
AU685310B2 (en) | 1998-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SK4397A3 (en) | Acyl azolones, manufacturing process thereof, pharmauceutical compositions on their base and process for producing them | |
SK4597A3 (en) | Urea and thiourea derivatives of azolones, process for the production, pharmauceutical compositions on their base and method for producing them | |
SK4497A3 (en) | Sulfonamide derivatives of azolones, method of producing, pharmaceutical composition on their base and their producing | |
US5650411A (en) | Substituted azolone derivatives | |
US5607932A (en) | Heterocyclic derivatives of azolones | |
US5710156A (en) | Ester and carbamate derivatives of azolones | |
CZ287159B6 (en) | 4-Quinolyl derivatives per se and for use as medicaments, process of their preparation and pharmaceutical preparations based thereon | |
EP0770072A1 (en) | Anti-helicobacter urea and thiourea derivatives of azolones | |
MXPA96004610A (en) | Ester derivatives and anti-helicobac azolone carbamate |